Ver mas grande
VTCN1 antibody
FT-FNab09461
Producto nuevo
100 µg
Comprando este producto generará 1 Biopunto. Su cesta contiene un total 1 Biopunto puede ser convertido en un Biobonos Descuento 4.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, IHC, WB |
| Target | VTCN1 |
| Research Area | Immunology, Cancer |
| Form | liquid |
| Recomended Dilution | WB: 1:200-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | V-set domain containing T cell activation inhibitor 1 |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | V-set domain-containing T-cell activation inhibitor 1|B7 homolog 4 (B7-H4)|B7h.5|Immune costimulatory protein B7-H4|Protein B7S1|T-cell costimulatory molecule B7x|VTCN1|B7H4 |
| Host | Rabbit |
| UniProt ID | Q7Z7D3 |
| Gene ID | 79679 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 50-80 kDa |
| Background | Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regul |
Más información
VTCN1 antibody